According to the Motley Fool's Dan Caplinger's article dated 14/dec/2012 "Has Geron Become the Perfect Stock?" there could be a new buyer in the market for Geron's stem cell technology !
" [Geron] is still trying to find a buyer for its stem-cell unit. Geron has a non-binding deal with BioTime (NYSEMKT: BTX ) for the division, but with speculation that Teva Pharmaceutical (NYSE: TEVA ) or another big pharma stock could make a competing bid ,Geron is hoping to get some cash to further its own research." writes Caplinger,
Could we be seeing a stem cell hub in the making ?
Teva's silence re its stem cell aspirations are deafening !!
dyor
re:what's up doc??
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |